TABLE 1.
Site | No. (%) of individuals in groupa |
|
---|---|---|
All participants (n = 544) | vRNA+ participants (n = 91) | |
A | 100 (18) | 0 (0) |
B | 108 (20) | 8 (9) |
C | 51 (9) | 10 (11) |
D | 128 (24) | 54 (59) |
E | 76 (14) | 14 (15) |
F | 81 (15) | 5 (5) |
The total numbers of samples tested included 3,591 NP swab samples for all participants, 179 NP swab samples for vRNA+ participants, 163 saliva samples all participants, and 0 saliva samples for vRNA+ participants.